Nucleic Acid-Tagged Small Molecule Libraries for High-Throughput Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for molecular recognition, such as monoclonal antibodies, peptides, and small molecule lead compounds, face challenges in efficiently screening and identifying target-specific binding molecules from large libraries, including issues with signal detection, specificity, and throughput.
Innovation Solution
The development of nucleic acid-tagged small molecule libraries using clonal DNA-bead complexes, where each bead is functionalized with a unique sequenceable molecule and tag sequence, allowing for high-density encoding and sensitive detection of bound molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If monoclonal antibodies are used for molecular recognition, then target-specific binding is achieved, but the method is complex and time-consuming due to hybridoma technology requirements
Solution Approach 1:
The patent extracts the essential function of molecular recognition from complex antibody systems and implements it using simple phage-displayed peptides. Instead of requiring full monoclonal antibody production through hybridoma technology, the invention uses only the antigen-binding fragment (peptide) displayed on phage particles, eliminating the need for cell fusion, antibody secretion, and purification steps while maintaining target-specific binding capability
Solution Approach 2:
The patent creates multiple copies of the peptide sequence encoded in phage DNA, allowing each phage particle to display identical peptide copies on its surface. This copying approach enables amplification of binding signals and facilitates selection of high-affinity binders through iterative phage display rounds, replacing the single-clone antibody production process
2Reliability
If phage display peptides are used for molecular recognition, then target-specific binding is achieved, but sensitivity is reduced compared to antibodies due to peptide stability issues
Solution Approach 1:
The patent optimizes peptide parameters including length, amino acid composition, and display density on phage particles to enhance binding sensitivity. By adjusting these parameters and selecting peptides with higher affinity through iterative display rounds, the system compensates for inherent peptide instability and achieves detection sensitivity comparable to or exceeding antibody-based methods
Solution Approach 2:
The patent performs preliminary selection of high-affinity peptide sequences through multiple rounds of phage display enrichment before actual detection applications. This pre-selection process identifies and amplifies only those peptide variants with optimal binding characteristics, ensuring maximum sensitivity is achieved before the peptides are used for actual molecular recognition tasks
3Stability of the object's composition
If small molecule lead compounds are used for molecular recognition, then chemical stability and purity are achieved, but screening throughput is low due to labor-intensive methods
Solution Approach 1:
The patent merges small molecule lead compounds with phage display technology by conjugating small molecules to phage particles or displaying them on phage surfaces. This combination allows small molecules to retain their chemical stability and purity while gaining the high-throughput capabilities of phage display, enabling parallel screening of thousands of compounds through affinity selection against target proteins
Solution Approach 2:
The patent uses phage particles as intermediaries to present small molecule lead compounds to target proteins. The phage acts as a carrier that delivers multiple copies of the small molecule or associated peptide to the target, enabling detection and selection of binding events that would be difficult to detect with single-molecule approaches, thereby increasing screening throughput while maintaining small molecule stability
4Adaptability or versatility
If large chemical libraries are screened, then diversity of candidates is increased, but detection sensitivity decreases due to signal dilution in the haystack
Solution Approach 1:
The patent segments the large chemical library into individual phage-displayed units, where each phage particle presents a single candidate molecule or peptide sequence. This segmentation allows each candidate to be evaluated independently while maintaining the diversity of the full library, as each phage acts as an isolated testing unit that can be detected without signal interference from other library members
Solution Approach 2:
The patent transitions from screening candidates in a homogeneous solution mixture to presenting them on two-dimensional phage particle surfaces. This dimensional change allows simultaneous presentation of diverse candidates in a spatially resolved format, enabling detection of binding events while maintaining library diversity, as bound phages can be separated and identified based on their unique sequences or markers
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid and sensitive screening of small molecule libraries, enhancing the identification of drug candidates and diagnostic reagents by ensuring each bead displays only one type of molecule and allowing for direct sequencing to determine the identity of bound chemicals.
Implementation Method 1
a tag sequence which is complementary to, and is hybridized to, said sequenceable molecule
Data Source
AI summary
The subject matter relates to relates to a one-bead-one-sequence composition, a library of tagged chemicals comprising a plurality of one-bead-one-sequence compositions, a method for identifying a candidate molecule from a library of tagged chemicals, and a composition produced by a process, all as described herein.